These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 2966313)

  • 1. Serotonin-1A receptor activation in hippocampal CA1 neurons by 8-hydroxy-2-(di-n-propylamino)tetralin, 5-methoxytryptamine and 5-hydroxytryptamine.
    Wu PH; Gurevich N; Carlen PL
    Neurosci Lett; 1988 Mar; 86(1):72-6. PubMed ID: 2966313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture.
    Dumuis A; Sebben M; Bockaert J
    Mol Pharmacol; 1988 Feb; 33(2):178-86. PubMed ID: 2828913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin agonist and antagonist actions in hippocampal CA1 neurons.
    Gurevich N; Wu PH; Carlen PL
    Can J Physiol Pharmacol; 1990 May; 68(5):586-95. PubMed ID: 2340447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiological effects of selective 5-HT1a and 5-HT1b ligands in rat hippocampus: comparison to 5-HT.
    Segal M; Azmitia EC; Whitaker-Azmitia PM
    Brain Res; 1989 Nov; 502(1):67-74. PubMed ID: 2531014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further evidence that indorenate is a 5-HT1 agonist.
    Benítez-King G; Chávez JL; Martínez I; Antón-Tay F; Hong E
    Proc West Pharmacol Soc; 1991; 34():433-7. PubMed ID: 1838609
    [No Abstract]   [Full Text] [Related]  

  • 6. 8-Hydroxy-2-(di-n-propylamino) tetralin is devoid of activity at the 5-hydroxytryptamine autoreceptor in rat brain. Implications for the proposed link between the autoreceptor and the [3H] 5-HT recognition site.
    Middlemiss DN
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Aug; 327(1):18-22. PubMed ID: 6238235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for 5-HT1A binding sites in chick embryo brain and discrimination by 5-methoxytryptamine.
    Soblosky JS; Dills C; DuMontier G; Jeng I
    Biochem Int; 1987 May; 14(5):797-803. PubMed ID: 2970262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased population spike amplitude in the dentate gyrus following systemic administration of 5-hydroxytryptophan or 8-hydroxy-2-(di-n-propylamino)tetralin.
    Klancnik JM; Baimbridge KG; Phillips AG
    Brain Res; 1989 Dec; 505(1):145-8. PubMed ID: 2532947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (+)-cis-8-Hydroxy-1-methyl-2-(di-n-propylamino)tetralin: a potent and highly stereoselective 5-hydroxytryptamine receptor agonist.
    Arvidsson LE; Johansson AM; Hacksell U; Nilsson JL; Svensson K; Hjorth S; Magnusson T; Carlsson A; Andersson B; Wikström H
    J Med Chem; 1987 Nov; 30(11):2105-9. PubMed ID: 2959776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 5-HT1-like receptor mediates a sympathetic ganglionic hyperpolarization.
    Gilbert MJ; Newberry NR
    Eur J Pharmacol; 1987 Dec; 144(3):385-8. PubMed ID: 2964375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hippocampal 8-[3H]hydroxy-2-(di-n-propylamino) tetralin binding site densities, serotonin receptor (5-HT1A) messenger ribonucleic acid abundance, and serotonin levels parallel the activity of the hypothalamopituitary-adrenal axis in rat.
    Burnet PW; Mefford IN; Smith CC; Gold PW; Sternberg EM
    J Neurochem; 1992 Sep; 59(3):1062-70. PubMed ID: 1379629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Hydroxytryptamine (5-HT)-induced endothelium-dependent relaxation of pig coronary arteries is mediated by 5-HT receptors similar to the 5-HT1D receptor subtype.
    Schoeffter P; Hoyer D
    J Pharmacol Exp Ther; 1990 Jan; 252(1):387-95. PubMed ID: 2137176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical evidence for the 5-HT agonist properties of PAT (8-hydroxy-2-(di-n-propylamino)tetralin) in the rat brain.
    Hamon M; Bourgoin S; Gozlan H; Hall MD; Goetz C; Artaud F; Horn AS
    Eur J Pharmacol; 1984 May; 100(3-4):263-76. PubMed ID: 6203761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticonflict effect of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).
    Engel JA; Hjorth S; Svensson K; Carlsson A; Liljequist S
    Eur J Pharmacol; 1984 Oct; 105(3-4):365-8. PubMed ID: 6239785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential responsiveness of the rat dorsal and median raphe 5-HT systems to 5-HT1 receptor agonists and p-chloroamphetamine.
    Blier P; Serrano A; Scatton B
    Synapse; 1990; 5(2):120-33. PubMed ID: 2137943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
    Tricklebank MD; Neill J; Kidd EJ; Fozard JR
    Eur J Pharmacol; 1987 Jan; 133(1):47-56. PubMed ID: 2881789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the 5-hydroxytryptamine receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin in different rodent models of epilepsy.
    Löscher W; Czuczwar SJ
    Neurosci Lett; 1985 Sep; 60(2):201-6. PubMed ID: 2932661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
    Millan MJ; Bervoets K; Colpaert FC
    J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin agonists inhibit synaptic potentials in the rat locus ceruleus in vitro via 5-hydroxytryptamine1A and 5-hydroxytryptamine1B receptors.
    Bobker DH; Williams JT
    J Pharmacol Exp Ther; 1989 Jul; 250(1):37-43. PubMed ID: 2526217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of serotonergic compounds on evoked responses in the dentate gyrus and CA1 region of the hippocampal formation of the rat.
    Klancnik JM; Obenaus A; Phillips AG; Baimbridge KG
    Neuropharmacology; 1991 Nov; 30(11):1201-9. PubMed ID: 1837848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.